The objectives of this study were to determine whether cardiac BCAA catabolism is defective in patients with dilated cardiomyopathy (DCM), and whether this occurs in conjunction with an impaired cardiac insulin signaling along with an activation of the mTOR pathway. This evidence concerns the gene MTOR and familial dilated cardiomyopathy.